CD34 and acute myeloid leukemia: Of note, in the same colony forming assay, combination treatment resulted in a greater magnitude of reduction in primary AML colony formation (average fold change 0.35 compared to vehicle control) when compared to that reduction seen with CD34 + cells (average fold change 0.54 compared to vehicle control).